Aim of the laboratory is to develop translational molecular medicine studies for novel targeted therapies
- Studies on molecular pathology mechanisms, genes, antigens and proteins directly involved in tumour, infectious and inflammatory diseases
- Development of therapeutic molecules and innovative strategies for drug delivery protocols by electric fields in models of human pathologies
- Administration of immunomodulatory molecules and systemic delivery of recombinant proteins by plasmid DNA in pre-clinical protocols
- Identification of biomarkers related to tumour, infectious and inflammatory diseases
- Validation of devices and new bio-materials to transfer in the clinical practice
Felix qui potuit rerum cognoscere causas
Virgilio - Georgiche (II, v. 490)